David Diemert
George Washington University
H-index: 38
North America-United States
Top articles of David Diemert
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1 …
The Lancet Infectious Diseases
2024/3/18
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
medRxiv: the preprint server for health sciences
2023/3/15
Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials
JAMA network open
2023/7/3
Jacqueline Miller
H-Index: 16
Eric Miller
H-Index: 25
Jayasree Krishnankutty
H-Index: 3
Amber Grant
H-Index: 2
Allison Green
H-Index: 1
Anthony Kim
H-Index: 32
Michael Desjardins
H-Index: 6
Jennifer A Johnson
H-Index: 11
Thomas Weiss
H-Index: 30
Carrie Johnston
H-Index: 2
Nadine Rouphael
H-Index: 28
Satoshi Kamidani
H-Index: 6
Gary Simon
H-Index: 19
Risk of COVID-19 after natural infection or vaccination
EBioMedicine
2023/10/1
Ying Huang
H-Index: 10
Eric Miller
H-Index: 25
Jayasree Krishnankutty
H-Index: 3
Amber Grant
H-Index: 2
Allison Green
H-Index: 1
Anthony Kim
H-Index: 32
Michael Desjardins
H-Index: 6
Jennifer A Johnson
H-Index: 11
Thomas Weiss
H-Index: 30
Carrie Johnston
H-Index: 2
Nadine Rouphael
H-Index: 28
Satoshi Kamidani
H-Index: 6
Gary Simon
H-Index: 19
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
Science Translational Medicine
2023/5/24
David Diemert
H-Index: 22
Jeffrey Bethony
H-Index: 39
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature medicine
2023/9
Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial
Research Square
2023/5/5
Nadine Rouphael
H-Index: 28
David Diemert
H-Index: 22
Susan Little
H-Index: 44
Evan Anderson
H-Index: 37
Richard Novak
H-Index: 24
Richard Rupp
H-Index: 8
Lisa Jackson
H-Index: 16
Lilly Immergluck
H-Index: 10
Dahlene Fusco
H-Index: 16
Stephen Walsh
H-Index: 8
Thomas Martin
H-Index: 9
Satoshi Kamidani
H-Index: 6
Michael Smith
H-Index: 19
Anna Wald
H-Index: 51
Mark Mulligan
H-Index: 32
David Stephens
H-Index: 26
Heather Hill
H-Index: 12
Jim Albert
H-Index: 17
Sam Wilks
H-Index: 5
Derek Smith
H-Index: 10
Immunogenicity of the BA. 1 and BA. 4/BA. 5 severe acute respiratory syndrome coronavirus 2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial
Clinical Infectious Diseases
2023/8/15
Immunogenicity of the BA. 1 and BA. 4/BA. 5 SARS-CoV-2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial
medRxiv
2023/3/31
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
PLOS Neglected Tropical Diseases
2023/3/30
Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs
Scientific reports
2023/2/17
Michael Smith
H-Index: 19
Sumanun Suwunnakorn
H-Index: 4
David Diemert
H-Index: 22
Sikandar Khan
H-Index: 11
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans
STAR protocols
2023/12/15
David Diemert
H-Index: 22
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3 …
EclinicalMedicine
2023/8/1
Joyce Wang
H-Index: 12
David Diemert
H-Index: 22
Adam Finn
H-Index: 22
Bo Fu
H-Index: 9
Paul Griffin
H-Index: 25
Rama Kandasamy
H-Index: 10
Sandra Mendoza
H-Index: 22
Patrick Mulholland
H-Index: 23
Nadine Rouphael
H-Index: 28
Howard Schwartz
H-Index: 14
Magdalena Sobieszczyk
H-Index: 24
Stephen Walsh
H-Index: 8
Judith White
H-Index: 9
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA. 1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
The Journal of infectious diseases
2023/12/15
Assessment of the Dissemination of COVID-19–Related Articles Across Social Media: Altmetrics Study
JMIR Formative Research
2023/7/12
Vaccine value profile for Hookworm
vaccine
2023/10/18
Rapid development of an integrated network infrastructure to conduct phase 3 COVID-19 vaccine trials
JAMA network open
2023/1/3
Karen Kotloff
H-Index: 49
Nadine Rouphael
H-Index: 28
Yuanyuan Zhang
H-Index: 12
Peter Gilbert
H-Index: 12
Lilly Immergluck
H-Index: 10
Jorge Pinto
H-Index: 11
Kathryn Stephenson
H-Index: 20
Stephen Walsh
H-Index: 8
Linda-Gail Bekker
H-Index: 66
Graeme Meintjes
H-Index: 58
David Bernstein
H-Index: 14
Dima Dandachi
H-Index: 9
Evan Anderson
H-Index: 37
Richard Rupp
H-Index: 8
Jorge Sanchez
H-Index: 3
Steve Shoptaw
H-Index: 41
Walter Jaoko
H-Index: 29
Mark Mulligan
H-Index: 32
Mary Olson
H-Index: 8
Immunogenicity of the BA. 1 and BA. 4/5 Bivalent Boosts: A Brief Report of Preliminary Results from the COVAIL Randomized Clinical Trial (preprint)
2023
Vaccination induces HIV broadly neutralizing antibody precursors in humans
Science
2022/12/2
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults
Vaccine
2022/10/6
